
zzso planned collection and analysis of adverse event zzso data are essential parts of zzso clinical zzso The zzso data in a trial zzso database should be comparable with what is stipulated in the protocol and with the zzso data zzso We examined whether the published zzso data differ from those in the zzso database and from the data collection requirements stated in study zzso 

We searched the National Cancer Institute zzso Clinical Data zzso System zzso for studies that used the Common zzso zzso version zzso and for which a final study publication was zzso We extracted from the protocols information pertaining to zzso collection and reporting methods and compared it with the methods cited in the zzso We also compared the zzso data in the trial publication with the zzso data submitted by the investigators to zzso 

We identified 22 studies meeting the criteria for this zzso There was considerable inconsistency between zzso collection and reporting methods cited in the protocols versus final zzso zzso data in the article and zzso were not zzso zzso percent of article high-grade zzso could not be matched to zzso zzso in the zzso zzso percent of zzso high-grade zzso could not be matched to zzso in the corresponding zzso In 14 of 22 articles, the number of high-grade zzso in zzso differed from the number in the articles by zzso or zzso 

Lack of consistency in and reporting of zzso are associated with zzso database and trial publication zzso data zzso 

